Outcomes of Patients with Renal Cell Carcinoma and Sarcomatoid Dedifferentiation Treated with Nephrectomy and Systemic Therapies: Comparison between the Cytokine and Targeted Therapy Eras

作者: Sarp K Keskin , Pavlos Msaouel , Kenneth R Hess , Kai-Jie Yu , Surena F Matin

DOI: 10.1016/J.JURO.2017.04.067

关键词: MedicineRetrospective cohort studyClear cellRenal cell carcinomaCarcinomaSurgeryBiopsyPrimary tumorUrologyTargeted therapyNephrectomy

摘要: Purpose: We studied overall survival and prognostic factors in patients with sarcomatoid renal cell carcinoma treated nephrectomy systemic therapy the cytokine targeted eras.Materials Methods: This is a retrospective study of who underwent received at our center era (1987 to 2005) or (2006 2015). Multivariate regression models were used determine association covariables survival.Results: Of 199 167 (83.9%) died (median 16.5 months, 95% CI 15.2–20.9). Survival clear histology was significantly longer vs those nonclear (p = 0.034). Patients synchronous metastatic disease had shorter than metachronous 12.1 23.3 p 0.0064). Biopsy primary tumor m...

参考文章(34)
Arie S Belldegrun, Arnold I Chin, John S Lam, Robert A Figlin, Surveillance Strategies for Renal Cell Carcinoma Patients Following Nephrectomy Reviews in urology. ,vol. 8, pp. 1- 7 ,(2006)
Mehrad Adibi, Arun Z. Thomas, Leonardo D. Borregales, Megan M. Merrill, Rebecca S. Slack, Hsiang-Chun Chen, Kanishka Sircar, Paari Murugan, Pheroze Tamboli, Eric Jonasch, Nizar M. Tannir, Surena F. Matin, Christopher G. Wood, Jose A. Karam, Percentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiation Urologic Oncology-seminars and Original Investigations. ,vol. 33, pp. 427- ,(2015) , 10.1016/J.UROLONC.2015.04.011
Thomas Cangiano, Joseph Liao, John Naitoh, Frederick Dorey, Robert Figlin, Arie Belldegrun, Sarcomatoid Renal Cell Carcinoma: Biologic Behavior, Prognosis, and Response to Combined Surgical Resection and Immunotherapy Journal of Clinical Oncology. ,vol. 17, pp. 523- 528 ,(1999) , 10.1200/JCO.1999.17.2.523
M. Dror Michaelson, Rana R. McKay, Lillian Werner, Michael B. Atkins, Eliezer M. Van Allen, Kara M. Olivier, Jiaxi Song, Sabina Signoretti, David F. McDermott, Toni K. Choueiri, Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor-risk metastatic renal cell carcinoma. Cancer. ,vol. 121, pp. 3435- 3443 ,(2015) , 10.1002/CNCR.29503
MIREIA CASTILLO, ANNA PETIT, BEGOÑA MELLADO, ANTONIO PALACÍN, JOAN B. ALCOVER, CARME MALLOFRÉ, C-kit expression in sarcomatoid renal cell carcinoma: potential therapy with imatinib. The Journal of Urology. ,vol. 171, pp. 2176- 2180 ,(2004) , 10.1097/01.JU.0000127727.33232.CF
Clayton Lau, Sumanta K. Pal, Jeremy O. Jones, Courtney Carmichael, Junmi Saikia, Joanne Hsu, Xueli Liu, Robert A. Figlin, Przemyslaw Twardowski, Clinical outcome in patients receiving systemic therapy for metastatic sarcomatoid renal cell carcinoma: A retrospective analysis☆ Urologic Oncology: Seminars and Original Investigations. ,vol. 31, pp. 1826- 1831 ,(2013) , 10.1016/J.UROLONC.2012.04.007
David M. Nanus, Alexandria Garino, Matthew I. Milowsky, Maureen Larkin, Janice P. Dutcher, Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinoma. Cancer. ,vol. 101, pp. 1545- 1551 ,(2004) , 10.1002/CNCR.20541
Mary E. Charlson, Peter Pompei, Kathy L. Ales, C.Ronald MacKenzie, A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation☆ Journal of Chronic Diseases. ,vol. 40, pp. 373- 383 ,(1987) , 10.1016/0021-9681(87)90171-8
M Staehler, N Haseke, A Roosen, T Stadler, M Bader, M Siebels, A Karl, CG Stief, SORAFENIB AFTER COMBINATION THERAPY WITH GEMCITABINE PLUS DOXORUBICINE IN PATIENTS WITH SARCOMATOID RENAL CELL CARCINOMA: A PROSPECTIVE EVALUATION European Journal of Medical Research. ,vol. 15, pp. 287- 291 ,(2010) , 10.1186/2047-783X-15-7-287
B Escudier, JP Droz, F Rolland, MJ Terrier-Lacombe, G Gravis, P Beuzeboc, B Chauvet, C Chevreau, JC Eymard, T Lesimple, Y Merrouche, S Oudard, F Priou, C Guillemare, S Gourgou, S Culine, None, Doxorubicin and Ifosfamide in Patients With Metastatic Sarcomatoid Renal Cell Carcinoma: A Phase II Study of the Genitourinary Group of the French Federation of Cancer Centers The Journal of Urology. ,vol. 168, pp. 959- 961 ,(2002) , 10.1016/S0022-5347(05)64551-X